Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Foley

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
The British Journal of Dermatology|January 23, 2025
Global Delphi consensus on treatment goals for generalized pustular psoriasisJonathan N Barker, Emmylou Casanova, Siew Eng Choon, et al.
The Australasian Journal of Dermatology|January 22, 2013
Treatment goals for moderate to severe psoriasis: an Australian consensusChristopher Baker, Alexandra Mack, Alan Cooper, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2Peter Foley, Kristian Reich, Andrew Blauvelt, et al.
Acta Dermato-Venereologica|October 7, 2021
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Mark Boguniewicz, et al.
Journal of the American Mosquito Control Association|October 28, 2006
Discovery of a widespread infestation of Aedes albopictus in the Torres Strait, AustraliaScott A Ritchie, Peter Moore, Morven Carruthers, et al.
The Australasian Journal of Dermatology|July 12, 2018
Psoriasis and cancer. An Australian/New Zealand narrativeMarius Rademaker, Diana M Rubel, Karen Agnew, et al.
Clinical and Experimental Dermatology|May 24, 2025
Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasisMark Lebwohl, Melinda J Gooderham, Richard B Warren, et al.
The Australasian Journal of Dermatology|May 14, 2025
Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology GroupMarius Rademaker, Peter Foley, Katherine Armour, et al.
Clinical Medicine (London, England)|April 1, 2015
Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathwaysPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
Brain Communications|June 6, 2022
Coupling cognitive and brainstem dysfunction in multiple sclerosis-related chronic neuropathic limb painPeter Foley, Yazhuo Kong, Ramune Dirvanskiene, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
The British Journal of Dermatology|January 23, 2025
Global Delphi consensus on treatment goals for generalized pustular psoriasisJonathan N Barker, Emmylou Casanova, Siew Eng Choon, et al.
The Australasian Journal of Dermatology|January 22, 2013
Treatment goals for moderate to severe psoriasis: an Australian consensusChristopher Baker, Alexandra Mack, Alan Cooper, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2Peter Foley, Kristian Reich, Andrew Blauvelt, et al.
Acta Dermato-Venereologica|October 7, 2021
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Mark Boguniewicz, et al.
Journal of the American Mosquito Control Association|October 28, 2006
Discovery of a widespread infestation of Aedes albopictus in the Torres Strait, AustraliaScott A Ritchie, Peter Moore, Morven Carruthers, et al.
The Australasian Journal of Dermatology|July 12, 2018
Psoriasis and cancer. An Australian/New Zealand narrativeMarius Rademaker, Diana M Rubel, Karen Agnew, et al.
Clinical and Experimental Dermatology|May 24, 2025
Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasisMark Lebwohl, Melinda J Gooderham, Richard B Warren, et al.
The Australasian Journal of Dermatology|May 14, 2025
Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology GroupMarius Rademaker, Peter Foley, Katherine Armour, et al.
Clinical Medicine (London, England)|April 1, 2015
Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathwaysPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
Brain Communications|June 6, 2022
Coupling cognitive and brainstem dysfunction in multiple sclerosis-related chronic neuropathic limb painPeter Foley, Yazhuo Kong, Ramune Dirvanskiene, et al.
Pageof 19